Susquehanna International Group, LLP Global Blood Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $4.06 Million - $8.54 Million	125,200 Added 113.2%	235,800 $16.1 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $517,360 - $867,448	23,200 Added 26.54%	110,600 $3.53 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $685,656 - $950,253	26,700 Added 43.99%	87,400 $3.03 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $747,000 - $1.21 Million	-30,000 Reduced 33.08%	60,700 $1.78 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $1.26 Million - $1.85 Million	49,500 Added 120.15%	90,700 $2.31 Million
Q2 2021 Aug 11, 2021	SELL	$32.46 - $43.42 $1.44 Million - $1.93 Million	-44,500 Reduced 51.93%	41,200 $1.44 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $2.82 Million - $3.68 Million	-72,400 Reduced 45.79%	85,700 $3.49 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $2.08 Million - $3.52 Million	55,200 Added 53.64%	158,100 $6.85 Million
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $3.78 Million - $5.33 Million	-71,600 Reduced 41.03%	102,900 $5.67 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $925,869 - $1.55 Million	-19,000 Reduced 9.82%	174,500 $11 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $10.3 Million - $21.5 Million	-247,000 Reduced 56.07%	193,500 $9.89 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $11.6 Million - $20.9 Million	254,900 Added 137.34%	440,500 $35 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $6.36 Million - $8.12 Million	-140,200 Reduced 43.03%	185,600 $9.01 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $6.14 Million - $7.39 Million	-116,800 Reduced 26.39%	325,800 $17.1 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $2.76 Million - $3.68 Million	68,900 Added 18.44%	442,600 $23.4 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $558,258 - $826,059	-17,700 Reduced 4.52%	373,700 $15.3 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $23.1 Million - $31.1 Million	-608,300 Reduced 60.85%	391,400 $14.9 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $26.3 Million - $34.1 Million	679,400 Added 212.11%	999,700 $45.2 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $693,000 - $1.15 Million	-17,500 Reduced 5.18%	320,300 $15.5 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $6.94 Million - $10.7 Million	233,800 Added 224.81%	337,800 $13.3 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $2.61 Million - $3.23 Million	104,000	104,000 $3.23 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account